Cargando…

Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease

Mortality rates following major lower extremity amputations (LEAs) 30 days–365 days postoperative have decreased, but 5-year rates remain high at 40.4%–70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to mortality mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeson, Summer A., Neubauer, Daniel, Calvo, Richard, Sise, Michael, Martin, Matthew, Kauvar, David S., Reid, Chris M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833438/
https://www.ncbi.nlm.nih.gov/pubmed/36699221
http://dx.doi.org/10.1097/GOX.0000000000004727
_version_ 1784868239996616704
author Beeson, Summer A.
Neubauer, Daniel
Calvo, Richard
Sise, Michael
Martin, Matthew
Kauvar, David S.
Reid, Chris M.
author_facet Beeson, Summer A.
Neubauer, Daniel
Calvo, Richard
Sise, Michael
Martin, Matthew
Kauvar, David S.
Reid, Chris M.
author_sort Beeson, Summer A.
collection PubMed
description Mortality rates following major lower extremity amputations (LEAs) 30 days–365 days postoperative have decreased, but 5-year rates remain high at 40.4%–70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to mortality more frequently than the amputation itself. Mortality rates between diabetic and nondiabetic patients were also analyzed. METHODS: The California Office of Statewide Health Planning and Development hospital database was queried for patients admitted January 1, 2007–December 31, 2018. ICD-9-CM codes identified patients with vascular disease and an amputation procedure. RESULTS: There were 26,669 patients. The 30-day, 90-day, 1-year, and 5-year major LEA mortality rates were 4.82%, 8.62%, 12.47%, and 18.11%, respectively. Weighted averages of 30-day, 90-day, 1-year, and 5-year major LEA mortality rates in the literature are 13%, 15.40%, 47.93%, and 60.60%, respectively. Mortality risk associated with vascular disease after amputation (hazard ratio = 22.07) was 11 times greater than risk associated with amputation-specific complications from impaired mobility (hazard ratio = 1.90; P < 0.01). Having diabetes was associated with lower mortality at 30 days, 90 days, and 1 year (P < 0.01) but not at 5 years (P = 0.22). CONCLUSIONS: This study suggests that people may be living longer after their major LEA than was previously thought. This study suggests that patients’ PAD may play a bigger role in contributing to their mortality than complications from loss of mobility postamputation. Although having diabetes was associated with lower postamputation mortality, the difference was no longer significant by 5 years.
format Online
Article
Text
id pubmed-9833438
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-98334382023-01-24 Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease Beeson, Summer A. Neubauer, Daniel Calvo, Richard Sise, Michael Martin, Matthew Kauvar, David S. Reid, Chris M. Plast Reconstr Surg Glob Open Reconstructive Mortality rates following major lower extremity amputations (LEAs) 30 days–365 days postoperative have decreased, but 5-year rates remain high at 40.4%–70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to mortality more frequently than the amputation itself. Mortality rates between diabetic and nondiabetic patients were also analyzed. METHODS: The California Office of Statewide Health Planning and Development hospital database was queried for patients admitted January 1, 2007–December 31, 2018. ICD-9-CM codes identified patients with vascular disease and an amputation procedure. RESULTS: There were 26,669 patients. The 30-day, 90-day, 1-year, and 5-year major LEA mortality rates were 4.82%, 8.62%, 12.47%, and 18.11%, respectively. Weighted averages of 30-day, 90-day, 1-year, and 5-year major LEA mortality rates in the literature are 13%, 15.40%, 47.93%, and 60.60%, respectively. Mortality risk associated with vascular disease after amputation (hazard ratio = 22.07) was 11 times greater than risk associated with amputation-specific complications from impaired mobility (hazard ratio = 1.90; P < 0.01). Having diabetes was associated with lower mortality at 30 days, 90 days, and 1 year (P < 0.01) but not at 5 years (P = 0.22). CONCLUSIONS: This study suggests that people may be living longer after their major LEA than was previously thought. This study suggests that patients’ PAD may play a bigger role in contributing to their mortality than complications from loss of mobility postamputation. Although having diabetes was associated with lower postamputation mortality, the difference was no longer significant by 5 years. Lippincott Williams & Wilkins 2023-01-11 /pmc/articles/PMC9833438/ /pubmed/36699221 http://dx.doi.org/10.1097/GOX.0000000000004727 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Reconstructive
Beeson, Summer A.
Neubauer, Daniel
Calvo, Richard
Sise, Michael
Martin, Matthew
Kauvar, David S.
Reid, Chris M.
Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_full Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_fullStr Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_full_unstemmed Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_short Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_sort analysis of 5-year mortality following lower extremity amputation due to vascular disease
topic Reconstructive
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833438/
https://www.ncbi.nlm.nih.gov/pubmed/36699221
http://dx.doi.org/10.1097/GOX.0000000000004727
work_keys_str_mv AT beesonsummera analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT neubauerdaniel analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT calvorichard analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT sisemichael analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT martinmatthew analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT kauvardavids analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT reidchrism analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease